On Monday, Immunic Inc (NASDAQ: IMUX) opened lower -12.57% from the last session, before settling in for the closing price of $1.83. Price fluctuations for IMUX have ranged from $0.95 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 56.87% at the time writing. With a float of $87.44 million, this company’s outstanding shares have now reached $90.08 million.
Considering the fact that the conglomerate employs 77 people, you should pay attention to its efficiency factor.
Immunic Inc (IMUX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunic Inc is 2.92%, while institutional ownership is 60.01%.
Immunic Inc (IMUX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.51 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.55) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.50% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Check out the current performance indicators for Immunic Inc (IMUX). In the past quarter, the stock posted a quick ratio of 3.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.64 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Compared to the last year’s volume of 0.55 million, its volume of 1.33 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 53.59%. Additionally, its Average True Range was 0.16.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 55.26%, which indicates a significant increase from 35.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.20% in the past 14 days, which was higher than the 72.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4488, while its 200-day Moving Average is $1.3203. Nevertheless, the first resistance level for the watch stands at $1.7955 in the near term. At $1.9911, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0938. If the price goes on to break the first support level at $1.4972, it is likely to go to the next support level at $1.3945. Now, if the price goes above the second support level, the third support stands at $1.1989.
Immunic Inc (NASDAQ: IMUX) Key Stats
There are currently 90,079K shares outstanding in the company with a market cap of 144.13 million. Presently, the company’s annual sales total 0 K according to its annual income of -93,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -21,380 K.
